With over €691 million in assets under management as of the end of 2017, Seventure Partners is a leading European venture capital firm. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in digital technologies, especially FinTech and AssurTech, in France and Germany, and in the life sciences field across Europe and North America. In life sciences, the four areas of focus include Biotechnology and Pharmaceuticals, Connected health and Medtech, Industrial biotechnology, and finally: MICROBIOME, nutrition, foodtech and personalized medicine.
Investments can range from €500 thousand to €10 million per round, or up to €20 million per company, from early to late stage. In December 2013, Seventure Partners successfully launched Health for Life Capital™ which has attracted strategic investments from prestigious organizations including Danone, Tereos, Tornier, Lesaffre, Bel and Novartis as well as entrepreneurs and financial institutions.
Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank.